Source: http://news.feedzilla.com/en_us/stories/politics/top-stories/272556591?client_source=feed&format=rss
brad paisley zac brown band aubrey born to run pranks pregnancy test april fools day 2012
Sunday, December 23, 2012
Saturday, December 22, 2012
NRA: Video game industry 'sows violence against its own people'
9 hrs.
After a week of intense anti-gun sentiment?following the shootings at Sandy Hook Elementary School, the National Rifle Association on Friday blamed?video games and their virtual guns?for creating a culture of violence that breeds killers.
"There exists in this country a callous, corrupt and corrupting shadow industry that sells, and sows, violence against its own people through vicious, violent video games with names like 'Bulletstorm,' 'Grand Theft Auto,' 'Mortal Kombat' and 'Splatterhouse,'" said?NRA?executive vice president Wayne LaPierre during a news conference that was interrupted by protesters. (See video above.)
While most of the games LaPierre listed are popular adult-themed games made by some of the biggest game companies in the world, the NRA chief?also called out a game called?"Kindergarten Killer" and asked why the media had ignored it.?
"How come my research department could find it and all of yours either couldn't or didn't want anyone to know you had found it?," he asked the press gathered in front of him.
If you know the name of the game, it's easy to find in a Web search, but it's not something someone is likely to stumble across.?That's because the simple, amateur Flash-animation game ? about a janitor who goes on a shooting spree in a school full of heavily armed children ? was posted in online forums a decade ago and?has never been for sale. There is no indication that the Newtown?shooter, 20-year-old?Adam Lanza, knew of its existence. Though a?Finnish site did remove the game after a shooting there, it is still available for free through other Flash sites.
LaPierre's accusations?come after lawmakers?and pundits earlier in the week?suggested that video games had played a role in the Newtown shootings. Though some reports suggest Lanza?played video games ranging from the family-friendly "Mario Party" to the violent "Call of Duty," investigators have yet to make any such connection.
While a new Gallup poll suggests that 47 percent of?Americans do think reducing gun violence in movies, TV and video games would be "very effective" in preventing mass shooting at schools,?researchers?and adolescent?psychiatrists have?spoken out this week, insisting?that the link between digital violence and real world violence is tenuous at best.?
"There is no good evidence that video games or other media contributes, even in a small way, to mass homicides or any other violence among youth," wrote?Chris Ferguson???professor of psychology and criminal justice at Texas A&M University and author of several studies on the subject,?in Time Magazine.
Meanwhile, in the wake of the real-world bloodshed, some gamers have called on their fellow players to take the time to examine their fascination with digital guns and violence.
Winda Benedetti?writes about video?games for NBC?News. You can follow her tweets about games and other things?on Twitter?here?@WindaBenedetti?and you can?follow her?on?Google+.?Meanwhile, be sure to check?out the?IN-GAME?FACEBOOK PAGE?to discuss the day's?gaming news and reviews.
buster posey eric holder eric holder carole king crystal renn matilda cab calloway
Ugandan shilling steady, seen weaker after Christmas holiday
KAMPALA (Reuters) - The Ugandan shilling was unchanged against the dollar on Friday but traders said they expected it to weaken once more active trading resumed next year.
At 1238 GMT commercial banks in Kampala quoted the currency of east Africa's third-largest economy at 2,645/2,655, unchanged from Thursday's close.
"The market is pretty flat because (dollar) demand is not there but going into 2013 we anticipate some small depreciation for the shilling," said Shahzad Kamaluddin, trader at Crane Bank.
"Considering the negative factors like a growing current account deficit, aid cuts and the central bank's loose policy stance I reckon the shilling will weaken when business resumes."
The shilling has lost 6.4 percent against the dollar this year but it has been strengthening since late November, lifted by decreased demand for the hard currency ahead of the year-end festivities.
Traders say the central bank's cuts to its key lending rate will keep yields on Ugandan government securities low and possibly erode the interest of offshore investors - whose dollar flows partly support the shilling's exchange rate.
At the last auction on November 29, the yield on the benchmark 91-day Treasury bill was unchanged from the previous auction at 9.8 percent.
Bank of Uganda is due to sell 110 billion shillings' worth of Treasury bills of all maturities on December 27.
The bank cut its key lending rate by 50 basis points to 12 percent this month, extending its policy easing cycle aimed at resuscitating economic growth.
"Because of low demand, market sentiment favours limited shilling appreciation for the remaining trading sessions of this year beyond which it (shilling) will come under pressure," said a trader at a leading commercial bank.
The central bank says Uganda's projected growth rate of about 4.3 percent for the 2012/13 (July-June) fiscal year is below the country's potential growth rate of around 7 percent.
Source: http://news.yahoo.com/ugandan-shilling-steady-seen-weaker-christmas-holiday-141652651--finance.html
Bret Bielema bob costas bowl projections bowl games sons of anarchy adriana lima blake shelton
CDC Provides New Update on Fungal Meningitis Outbreak of 2012
The health risks of the fungal meningitis outbreak of 2012 that began in mid-September are still not behind those people unfortunate enough to have received contaminated injections of methylprednisolone acetate manufactured and shipped by the New England Compounding Center to outpatient facilities in 19 states.
CDC's December 20 Health Alert Update
The U.S. Centers for Disease Control and Prevention issued a health update yesterday, alerting physicians to the continued concern for the development of spinal or paraspinal infections in those who had received injections of MPA before the recall of the potentially contaminated drug on Sept. 26.
For the more than 13,000 people who received injections into their backs in one of the 19 states known to have received shipments of any one of three contaminated batches of MPA who have not yet been sickened by them, there is increased reason for concern about the possibility of infections below the skin at or near the spinal injection site.
According to NBCNews.com , researchers from three of the 19 affected states had magnetic resonance imaging tests performed on 128 of such people who now had new or worsening symptoms, such as injection site pain. The MRI testing revealed 52 percent of those tested had signs of an active infection, ranging from an abscess to infection of the bone.
What the Newest Health Alert Means to Affected People
The CDC's latest update repeats the recommendations provided to clinicians on Nov. 20, namely to use an assertive approach in obtaining an MRI with contrast testing for anyone known to have received the contaminated spinal injections and who have new or worsening symptoms.
In addition, the federal agency is recommending clinicians also consider an MRI with contrast testing for people who had received the contaminated spinal injections but have only a persistence of the same symptoms they've had all along, namely back pain. Due to the chronic pain experienced by these individuals, they may not notice any new, subtle symptoms.
Current Data on Fungal Meningitis Outbreak 2012
Although neither physician knew it at the time, the actions of Dr. April Pettit, a Tennessee physician, and Dr. Marion Kainer of the Tennessee Department of Health in the identification of fungus as a cause of a recently diagnosed case of meningitis and then linking the source of the infection to a contaminated injectable drug used in spinal injections, was the beginning of a public health nightmare .
As of Dec. 17, 620 individuals have suffered some sort of adverse condition secondary to having received either contaminated spinal injections or joint injections. Three hundred sixty-seven of those people have been diagnosed with fungal meningitis and 218 people have been diagnosed with infections of the spine or paraspinal area. The outbreak has claimed the lives of 39 people.
Smack dab in the middle of the baby boomer generation, L.L. Woodard is a proud resident of "The Red Man" state. With what he hopes is an everyman's view of life's concerns both in his state and throughout the nation, Woodard presents facts and opinions based on common-sense solutions.
Source: http://news.yahoo.com/cdc-provides-fungal-meningitis-outbreak-2012-221200344.html
red dawn sweet potato pie sweet potato pie green bean casserole recipe Kmart Black Friday PlanetSide 2 Alexis DeJoria
Syrian rebels say will target Aleppo airport
BEIRUT (Reuters) - Syrian rebels warned on Friday they will target the international airport of the northern city of Aleppo after firing at an airliner preparing to take off, the first direct attack on civilian a flight in the 21-month-old revolt.
Thursday's attack was another sign of the growing confidence of rebels who are also fighting an offensive in the central province of Hama, pursuing a string of territorial gains to try to cut army supply lines and pressure the capital Damascus to the south.
A rebel commander who gave his name as Khaldoun told Reuters by Skype that snipers from the Intelligence Armed Struggle Battalion, part of the Islamist Jundallah brigade, had hit the wheels of Syrian Airways flight RB201 on Thursday.
"Those were warning shots," he said, adding that the plane had been unable to take off. "We wanted to send a message to the regime that all their planes - military and civilian - are within our reach."
There was no immediate mention of the incident on Syrian state media.
Rebels accuse the government of using civilian aircraft to transport weapons and Iranian fighters who they say are helping President Bashar al-Assad's forces. Insurgents have cut off many of the road links to Aleppo, Syria's biggest city.
Fighting around Damascus has made the road to the capital's international airport unsafe for traffic. Foreign airlines have stopped flying there. According to flight schedules, the Cairo-bound RB201 usually flies from Damascus rather than Aleppo.
"What happened with Damascus airport will happen to Aleppo, even if the price is higher," Khaldoun said.
Another rebel urged civilians not to use Aleppo airport or Syrian Air flights "as they will be targets from now on".
"SCUD-TYPE MISSILES" FIRED
The rebels have scored advances across the country, announcing on Friday they had taken over Rayhaneya town in rural Damascus and several other towns in Hama.
Western powers and some regional countries fear that the more the Syrian government is weakened the more dangerous its response may become.
In what he described as acts of "a desperate regime approaching collapse", NATO chief Anders Fogh Rasmussen said that Assad's forces had fired more Scud-type missiles. "I can confirm that we have detected the launch of Scud-type missiles. We strongly regret that act."
A NATO source said there had been multiple launches of Scud-type missiles inside Syria on Thursday morning.
A video posted on Youtube showed what appeared to be Syrian soldiers firing a long-range missile which opposition activists said was a Scud, launched last week. It was not possible to verify the authenticity of the video or dates and location.
Rasmussen said the Scud launches justified NATO's decision to dispatch Patriot anti-missile systems to NATO ally Turkey - a deployment criticized by Syria, Iran and Russia.
"The fact that such missiles are used in Syria emphasizes the need for effective defense protection of our ally Turkey," he told reporters at NATO headquarters.
"The recent launch of missiles has not hit Turkish territory but of course there is a potential threat and this is exactly the reason why NATO allies decided to deploy Patriot missiles in Turkey," he said.
DRUZE-SUNNI TENSION
Syrian forces shelled the town of Moadamiah southwest of Damascus on Friday, killing at least 15 people and wounding dozens who were taking refuge in a residential compound.
"They fired several rockets at the neighborhood where hundreds of people were hiding. The field hospitals are now unable to take in more wounded. The numbers are big," said Murad al-Shami from Damascus.
The revolt against Assad began with peaceful protests calling for greater freedoms but after a heavy security crackdown turned into a civil war largely pitting the Sunni majority against the Alawite sect to which Assad belongs.
Other minorities like Druze, Christians and Shi'ites fear for their freedoms with the growing influence of Sunni Islamist hardliners in the armed revolt.
Opposition activists and rebels said on Friday they were trying to defuse tension between Druze in Sweida province and Sunni fighters from neighboring Deraa province, cradle of revolt against Assad.
The reason behind the confrontation was not immediately clear, but an activist said it started when fighters attacked a government checkpoint in Sweida killing and kidnapping several people, several of them Druze. Residents in the area were angered and in return attacked and kidnapped rebels.
"They exchanged kidnappings and threats but everybody is working on sorting it out," a Druze activist said.
Sweida, home to Syria's Druze minority, is solidly under state control. Most Syrian Druze have stayed on the sidelines of the revolt.
"What happened in the past days breaks the heart and is unacceptable to any free man ... We are confident that we will get out of it," said Mouaz Alkhatib, leader of the newly formed opposition coalition.
"Clashes between neighbors and brothers mean one thing - weakening the revolution and empowering the regime," he said in a statement. "I call on all my people and loved ones to look for a brotherly solution and not to threaten (each other) or kidnap civilians and innocent people".
(Editing by Jon Hemming)
Source: http://news.yahoo.com/syrian-rebels-fight-strategic-town-hama-province-095210843.html
russell wilson catch me if you can delmon young arrested the raven the raven zerg rush david wilson
GE to buy aviation unit of Italy's Avio for $4.3B
FAIRFIELD, Conn. (AP) ? Industrial conglomerate General Electric plans to buy the aviation business of Italian manufacturer Avio for $4.3 billion to grow its jet propulsion business and strengthen its supply chain.
The Fairfield, Conn., company said Friday that it wants to build its supply chain as it ramps up engine production. The deal also gives GE a chance to offer Avio products outside the aviation industry, in power generation, oil and marine products.
GE will buy Avio S.p.A.'s aviation business from European private equity firm Cinven and the Italian aerospace group Finmeccanica.
Avio has supplied GE Aviation since 1984. The company, which is based in Turin, Italy, employs about 5,300 people. It makes aviation propulsion components and systems for civilian and military aircraft, including low-pressure turbine systems, accessory gearboxes, geared systems and combustors. Last year, its aviation business generated $2.4 billion in revenue, more than half of which was derived from components for GE and GE joint venture engines.
GE isn't buying Avio's space unit, which employs 800 people.
Associated Pressus soccer bobby brown arrested the happening black panthers mauritania obama open mic jefferson county colorado
Friday, December 21, 2012
Canadian economy returns to growth, advances 0.1 per cent in October
OTTAWA - Statistics Canada says the country's economy returned to growth in October, although at a sluggish pace.
The 0.1 per cent advance follows a flat reading in September and a 0.1 per cent contraction in August that had contributed to Canada's worst quarter of economic growth in over a year.
The October performance, which was in line with economist estimates, starts the fourth quarter off on a welcome positive note.
The agency says the major contributors during the month were wholesale trade, which rose 0.8 per cent from the previous month, and retail trade, which increased 0.3 per cent.
Oil and gas extraction increased by 0.4 per cent, and utilities advanced by 1.2 per cent.
But there was also continuing weakness in manufacturing, down 0.4 per cent; mining, also 0.4 per cent lower; construction, down 0.1 per cent; and real estate agents and brokers, which registered a 1.4 per cent decline.
Overall, the goods producing industries were flat in October, while the services sector gained 0.1 per cent.
From a year ago, the goods industries remained in negative territory, down 0.1 per cent, while services contributed 1.7 per cent to economic growth.
Source: http://news.yahoo.com/canadian-economy-returns-growth-advances-0-1-per-134551214.html
mauritania obama open mic jefferson county colorado extenze tenacious d steve smith zou bisou bisou
Thursday, December 20, 2012
Study: 39,000 Ohio jobs linked to shale oil, gas production
By? Dan Gearino
Ohio this year has 39,000 jobs linked to shale oil and gas production, a number that is projected to more than triple by the end of the decade, according to a new report.
Shale oil and gas accounts for $4.1 billion of the value of the goods and services produced in Ohio this year, a number that will rise to $18 billion in 2020 and $35 billion in 2035, said the national report by the research firm IHS Global Insight.
The IHS report is the most recent of several studies that make estimates on the moving target of shale development.
?The unconventional oil and gas revolution is having a bigger impact across the country, including in nonproducing states, than is generally recognized,? said Daniel Yergin, vice chairman of IHS, in a statement. ?What we found is that the economic and financial links reach out across all the states in our highly-interconnected national economy.?
The report was financed by business groups that support shale drilling, including the American Petroleum Institute and America?s Natural Gas Alliance.
Ohio has approved more than 500 permits to drill horizontal wells in the Marcellus and Utica shale formations, according to the state Department of Natural Resources. Oil and gas are extracted through a process called hydraulic fracturing, or fracking.
The state ranks ninth out of the top 10 for production related to shale oil and gas, a group led by Texas and Pennsylvania. As group, the top 10 will contribute 1.2 million jobs and $178 billion to their state economies this year.
For some perspective, the $4.1 billion worth of Ohio goods and services, is roughly 1 percent of the state?s total for 2011; this measure, called gross domestic product, is tracked by the Bureau of Economic Analysis.
On the employment total, 39,000 jobs is a little more than half of 1 percent of the state?s current total work force. IHS says the shale jobs will hit 144,000 by 2020 and 267,000 by 2035.
The growth projections assume that oil and gas prices will be high enough to encourage further investment. Estimating the commodity prices and their effect on employment is one of the most difficult parts of making such a report, said Daniel Meges, an economist at Chmura Economics & Analytics in Cleveland.
?Ultimately employment depends on drilling,? he said. ?Nobody gets employed unless they are drilling wells. They are not going to drill too much if the price of gas is too low.?
Prices are low right now, but have been rising.
Meges? firm issued a report of its own, showing that Ohio has 25,000 jobs related to shale oil and gas as of 2011. Working on the report, he learned the difficulty in deciding which jobs are connected to oil and gas drilling. His estimate was on the conservative side, including employees and independent contractors directly involved with the industry.
?If you add in the lawyers that are running around southwestern Ohio right now and you throw in some engineering consulting, you could get some big numbers,? he said.
The IHS study found that the largest employers in Ohio?s industry are administrative and support services, scientific and technical services, and manufacturing.
The report also looks at how drilling will contribute to the economies of all 32 states where there is no drilling activity, including jobs in manufacturing and legal and financial services. ?
dgearino@dispatch.com
@dispatchenergy
safehouse brown recluse brown recluse front door alyssa bustamante protandim weightless
Global Markets for Diabetes Therapeutics and Diagnostics -- Focus on Europe
NEW YORK, Dec. 20, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Markets for Diabetes Therapeutics and Diagnostics -- Focus on Europe
http://www.reportlinker.com/p01057717/Global-Markets-for-Diabetes-Therapeutics-and-Diagnostics----Focus-on-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
INTRODUCTIONSTUDY GOALS AND OBJECTIVESThe aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for drugs used in the treatment of diabetes and for devices and instruments used in the diagnosis and monitoring of diabetes. Special emphasis is given to major forces contributing to the vigorous growth of the diabetes market. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2017. These forecasts are based on epidemiological data and projections, as well as on information about R&D trends and differential market potential on a country-by-country basis. Health care policies, demographics, and the wider economic environment are also taken into account.
REASONS FOR DOING THE STUDY
It is widely recognized that the prevalence of the most common type of diabetes mellitus, Type 2, is now reaching epidemic proportions all over the world. Cases of Type 1 diabetes are also on the rise, although to a less spectacular degree. These trends are of great concern, not only to the individuals affected, but also to governments and providers of health care. Indeed, the economic consequences of diabetes are vast, involving not only the direct burden of managing the disease but also the common and often catastrophic complications such as cardiovascular disease, peripheral neuropathy, and blindness.
Prompt diagnosis and effective treatment of diabetes are essential, not optional, priorities for governments and health care agencies. The already large market for diabetes monitoring and treatment will certainly grow in line with increasing incidence and with improvements in diagnosis. Thus diabetes is of great commercial significance to the suppliers of drugs used in treatment and to the suppliers of devices needed for disease monitoring.
Among the information needs of companies in this field is an accurate and up-to-date assessment of the current extent of the diabetes epidemic, its likely evolution over the next five years, and the impact of drugs and technical developments now in the pipeline.
SCOPE OF REPORT
This report discusses the implications of the above-mentioned trends in the context of the current size and growth of the diabetes market, discussed both in global terms and in terms of the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on merger and acquisition (M&A) activity. Five-year global sales forecasts are provided for main drug and device categories, and breakdowns are provided for several national markets.
A comprehensive refresher course on diabetes is provided as an appendix.
MARKET ANALYSES AND FORECASTSThe dimensions of the surging diabetes epidemic can be witnessed in stark outline against previous smaller estimates only a few years back. Increased awareness of this "modern plague" has led naturally to improved and more frequent testing practices. This new awareness has also led to improved treatment compliance by patients. Added to these are the more expensive therapies and increased penetration of continuous glucose monitoring (CGM) approaches, which all combine to build a public health menace of accelerating proportions.For the purpose of market analyses in this report, the global market is defined as 13 countries which together make up over 80% of the total diabetes universe. These countries are the U.S., Canada, Brazil, Mexico, China, India, Japan, Russia, Germany, France, Italy, Spain and the U.K.
Market figures are based on revenues at the manufacturer level and are projected at 2012-dollar value without attempting to predict the effect of inflation/deflation. Therapeutic categories discussed include insulins and oral hypoglycemic agents, devices including blood glucose monitors and accessories, and software aids to self-management of diabetes by patients.
METHODOLOGYPrimary research for this report included interviews with leading individuals in relevant companies and medical associations; primary sources of published data include epidemiological and economic studies, company annual reports, SEC filings, and government publications. Secondary sources consisted of literature searches, industry journals, and other commercial publications. Data for market estimates and forecasts were pooled from a range of sources, critically assessed by BCC.INTENDED AUDIENCEThis report is designed to satisfy the information needs of a wide variety of individuals involved in the diabetes marketplace, including company senior management executives seeking to base their strategic decisions on the best available information with regard to market forces and trends. However, it is also aimed at managers and executives in marketing, research, planning, and sales departments who need readable, comprehensive, and up-to-date background information on the marketplace in which they are operating.INFORMATION SOURCESSources of information included marketing strategists, industry executives, government and professional agencies, and surveys of physicians. Company annual reports and SEC filings, journal articles, and data from health care institutions were also mined, as well as publications of relevant associations such as the International Diabetes Federation and the American and British Diabetic Associations.ANALYST CREDENTIALSPaul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous reports on the diabetes marketplace covering both therapeutic and monitoring aspects.TABLE OF CONTENTSCHAPTER 1 INTRODUCTION 1STUDY GOALS AND OBJECTIVES 1
REASONS FOR DOING THE STUDY 1
SCOPE OF REPORT 1
MARKET ANALYSES AND FORECASTS 2
METHODOLOGY 2
INTENDED AUDIENCE 2
INFORMATION SOURCES 2
ANALYST CREDENTIALS 2
RELATED REPORTS 3
BCC ONLINE SERVICES 3
DISCLAIMER 3
CHAPTER 2 SUMMARY 5
THE DIABETES MARKET 5
LEADING COMPANIES 5
SUMMARY TABLE DIABETES MARKET BREAKDOWN BY REGIONS, THROUGH 2017 ($
BILLIONS) 6
SUMMARY FIGURE DIABETES MARKET EVOLUTION BY REGION, 2011-2017 ($ BILLIONS) 6
CHAPTER 3 OVERVIEW 8
DIABETES BASICS 8
STRUCTURE OF THE DIABETES MARKET 8
DRIVERS FOR GROWTH 8
RISING PREVALENCE 8
TABLE 1 GLOBAL AND REGIONAL DIABETES PREVALENCE, 2011 AND 2017 (CASES IN
MILLIONS) 8
NEW TECHNOLOGY 9
RATE OF MARKET GROWTH 10
CURRENT TREATMENT OF DIABETES 10
INSULIN 10
Insulin Administration Devices 10
ORAL ANTIDIABETIC DRUGS 11
MONITORING DEVICES FOR DIABETES 11
TABLE 2 TOTAL DIABETES MARKET IN 2012 ($ BILLIONS) 11
REGIONAL SEGMENTATION 11
TABLE 3 ADULT DIABETES MARKET BY REGION (MILLIONS/%) 12
MARKET GROWTH 12
THE DIABETES INDUSTRY 12
PHARMACEUTICAL COMPANIES 12
MEDICAL DEVICE COMPANIES 13
CHAPTER 4 PRODUCTS AND SUPPLIERS 15
INSULIN 15
HISTORY 15
Bovine and Porcine Insulin 16
Humanized Insulin 16
COMPANIES SUPPLYING INSULIN 17
Eli Lilly 17
Sanofi 17
Novo Nordisk 17
Some Other Suppliers 17
Wockhardt Limited: India 17
BioconB: India 18
Shreya Life Sciences: India 18
Diosynth: the Netherlands 18
TABLE 4 MAJOR BRANDS OF INSULIN 18
INSULIN DELIVERY 19
SYRINGES 19
INSULIN SYRINGE MANUFACTURERS 19
Becton Dickinson 19
Owen Mumford 20
Terumo 20
B. Braun 20
PENS 20
TABLE 5 INSULIN PENS 21
MANUFACTURERS OF INSULIN PENS 21
Novo Nordisk 21
Owen Mumford 22
Other Makers 22
INJECTORS 22
INJECTOR MANUFACTURERS 23
Activa Brand Products 23
Antares Pharma 23
Bioject 23
MediCool Inc. 23
Owen Mumford 24
Palco Labs Inc. 24
Rosch AG Medizintechnik 24
INSULIN PUMPS 24
What Is an Insulin Pump? 24
The Infusion Set 25
Candidates for Pump Therapy 25
COMPANIES SUPPLYING INSULIN PUMPS 26
Animas Corp. 26
Sooil Development Co. 27
Medtronic MiniMed 27
Nipro Diabetes Systems 27
Roche Insulin Delivery Systems 27
Insulet 27
Tandem Diabetes Care 28
TABLE 6 INSULIN PUMPS 28
Problems with Pumps-or Users? 28
ORAL HYPOGLYCEMIC DRUGS 29
SULFONYLUREAS 29
TABLE 7 SULFONYLUREAS 29
BIGUANIDES 30
ALPHA-GLUCOSIDASE INHIBITOR 30
GLITAZONES 30
PRANDIAL GLUCOSE REGULATORS 30
GLP-1 ANALOGS; ALSO KNOWN AS INCRETIN MIMETICS 31
AMYLIN MIMETIC 31
TABLE 8 ORAL HYPOGLYCEMICS 32
DIAGNOSIS AND MONITORING 32
THE ROLE OF SELF-MONITORING 32
SMBG Frequency 33
BLOOD GLUCOSE MONITORING DEVICES: SUPPLIERS AND PRODUCTS 33
Lancets 34
TABLE 9 INTERNATIONAL SUPPLIERS OF BLOOD LANCETS 34
BLOOD-SAMPLING DEVICES 34
Bayer Diagnostics 34
Becton Dickinson 35
Cell Robotics 35
LifeScan 35
Roche Diagnostics 35
BLOOD GLUCOSE MONITORS 35
77 Elektronika Kft 35
Abbott Laboratories 36
Acon Laboratories Inc. 36
AgaMatrix Inc. 36
Apex Biotechnology Corp. 37
Arkray USA 37
Aventir Biotech LLC 37
Bayer Corp. 37
Belbiosens 38
Diagnostic Devices Inc. 38
Eumed Biotechnology Co. Ltd. 38
GlucoPlus Inc. 38
HMD Bio Medical 38
Health & Life Co. 38
HemoCue AB 39
Home Diagnostics Inc. 39
Hypoguard 39
i-SENS Inc. 39
LifeScan Inc. 39
Medtronic 39
Menarini Diagnostics 40
National Diagnostic Products 40
Novabiomedical Corp. 40
Roche 40
TaiDoc Technology Corp. 41
US Diagnostics Inc. 41
GLUCOSE METER ACCURACY 41
OTHER TESTING APPROACHES 42
HEMOGLOBIN A1C 42
Hemoglobin A1c Meters 42
Hemoglobin A1c Kits 43
SOFTWARE AIDS TO DIABETES MONITORING 44
AIDA On-Line 44
Bayer Care: Blood Sugar Log 44
Body Sigma 44
Dailyrating 44
DiabetEASE 44
Diabetes Assistant 45
Diabetes Homecare Center 45
Ecivon 45
HealthEngage Diabetes 45
Lifeclinic 46
PlasmaGlucose 46
Symcare 46
CHAPTER 5 NEW DEVELOPMENTS IN DIABETES 48
APPROACHES BASED ON CURRENT TECHNOLOGY 48
NOVEL INSULIN DELIVERY TECHNOLOGY 48
Oral-Lyn 48
Oramed 48
Medingo Micro-Pump Patch 48
Inhaled Insulin 49
Transdermal Approach 49
IMPROVED ORAL ANTIDIABETIC DRUGS 50
Dutogliptin 50
Byetta LAR 50
Lixisenatide 50
NEW DEVELOPMENTS IN GLUCOSE TESTING 51
Continuous Glucose Monitoring (CGM) 51
Reimbursement 52
Noninvasive Monitoring 52
TABLE 10 SELECTED COMPANIES DEVELOPING NONINVASIVE GLUCOSE MONITORING 55
Integrated Testing 56
ARTIFICIAL PANCREAS 57
Roche 57
Abbott 58
Novo Nordisk/LifeScan 58
Animas 58
RADICAL APPROACHES 59
ALTERNATIVES TO INSULIN 59
IMMUNOTHERAPY 60
TRANSPLANTATION 60
CELL AND STEM CELL THERAPIES 61
GENE THERAPY 62
Gene Therapy Approaches for Expressing Insulin 62
Gene Therapy Approaches for Immunomodulation 62
Gene Therapy Approaches for Cell-Based Therapies 62
A NEW AGE OF MOBILITY IN DIABETES MANAGEMENT 63
THE IMPACT OF NEW DEVELOPMENTS ON THE DIABETES MARKET 64
CHAPTER 6 THE GLOBAL DIABETES MARKET 67
MARKET COMPONENTS 67
SIZE 67
TABLE 11 GLOBAL DIABETES MARKET, 2011 ($ BILLIONS) 67
GROWTH 68
MARKET ANALYSIS BY PRODUCT CATEGORY 68
INSULINS AND INSULIN DELIVERY DEVICES 68
Major Suppliers 69
TABLE 12 GLOBAL SALES OF LEADING INSULIN PRODUCTS, 2011 ($ MILLIONS) 69
OTHER ANTIDIABETIC DRUGS 69
Major Suppliers 69
TABLE 13 SALES OF OTHER ANTIDIABETIC DRUGS, 2011 ($ MILLIONS) 70
INSULIN PUMPS 70
TABLE 14 DIABETES MARKET BREAKDOWN BY REGION, THROUGH 2017 ($ BILLIONS) 71
MONITORING PRODUCTS 71
Major Suppliers 71
TABLE 15 LEADING SUPPLIERS OF GLUCOSE MONITORING PRODUCTS, 2011 (MILLIONS/%) 71
TRENDS 71
REGIONAL SEGMENTATION 72
TABLE 16 RISING PREVALENCE OF DIABETES BY REGION, THROUGH 2017 (CASES IN
MILLIONS) 72
NATIONAL MARKETS 72
North America 73
TABLE 17 TOTAL DIABETES MARKET FOR CANADA AND THE U.S., THROUGH 2017 ($
BILLIONS) 73
South and Central America 74
TABLE 18 TOTAL DIABETES MARKET FOR MEXICO AND BRAZIL, THROUGH 2017 ($
BILLIONS) 74
Europe 74
TABLE 19 MAJOR EUROPEAN ECONOMIES: TOTAL DIABETES MARKET, THROUGH 2017 ($
BILLIONS) 75
Asia 75
TABLE 20 MAJOR ASIAN COUNTRIES: TOTAL DIABETES MARKET, THROUGH 2017 ($
BILLIONS) 75
CHAPTER 7 THE EUROPEAN MARKET 77
FRANCE 77
VITAL STATISTICS 77
HEALTH AND HEALTH CARE 77
PROVISION OF HEALTH CARE 77
FRANCE'S PHARMACEUTICAL MARKET 78
THE DIABETES MARKET 78
TABLE 21 PREVALENCE OF DIABETES IN FRANCE, THROUGH 2017 (CASES IN MILLIONS) 79
TABLE 22 FRANCE: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 79
TABLE 23 FRANCE: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 79
GERMANY 79
VITAL STATISTICS 80
HEALTH AND HEALTH CARE 80
PROVISION OF HEALTH CARE 80
GERMANY'S PHARMACEUTICAL MARKET 80
PRICE CONTROLS 81
THE DIABETES MARKET 81
TABLE 24 PREVALENCE OF DIABETES IN GERMANY, THROUGH 2017 (CASES IN MILLIONS) 82
TABLE 25 GERMANY: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 82
TABLE 26 GERMANY: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 82
ITALY 82
VITAL STATISTICS 82
HEALTH AND HEALTH CARE 83
PROVISION OF HEALTH CARE 83
ITALY'S PHARMACEUTICAL MARKET 83
IMPLICATIONS FOR RESEARCH 85
THE DIABETES MARKET 85
TABLE 27 PREVALENCE OF DIABETES IN ITALY, THROUGH 2017 (CASES IN MILLIONS) 86
TABLE 28 ITALY: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 86
TABLE 29 ITALY: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 86
RUSSIA 86
VITAL STATISTICS 86
HEALTH AND HEALTH CARE 87
PROVISION OF HEALTH CARE 87
RUSSIA'S PHARMACEUTICAL MARKET 87
PHARMA 2020 87
THE DIABETES MARKET 88
TABLE 30 PREVALENCE OF DIABETES IN RUSSIA, THROUGH 2017 (CASES IN MILLIONS) 89
TABLE 31 RUSSIA: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 89
TABLE 32 RUSSIA: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 89
SPAIN 89
VITAL STATISTICS 89
HEALTH AND HEALTH CARE 90
PROVISION OF HEALTH CARE 90
PHARMACEUTICAL SERVICES 90
SPAIN'S PHARMACEUTICAL MARKET 91
THE DIABETES MARKET 91
TABLE 33 PREVALENCE OF DIABETES IN SPAIN, THROUGH 2017 (CASES IN MILLIONS) 92
TABLE 34 SPAIN: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 92
TABLE 35 SPAIN: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 92
THE UNITED KINGDOM 92
VITAL STATISTICS 93
HEALTH AND HEALTH CARE 93
PROVISION OF HEALTH CARE 93
Private Sector Involvement 93
PHARMACEUTICALS 94
THE UNITED KINGDOM'S PHARMACEUTICAL MARKET 94
THE DIABETES MARKET 95
TABLE 36 PREVALENCE OF DIABETES IN THE U.K., THROUGH 2017 (CASES IN MILLIONS) 95
TABLE 37 U.K.: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 96
TABLE 38 U.K.: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 96
CHAPTER 8 COMPANY PROFILES 98
LEADING COMPANIES 98
ABBOTT LABORATORIES 98
Overview 98
ABBOTT DIABETES CARE, INC. 99
BAYER AG 99
Overview 99
Diabetes Products 100
BECTON DICKINSON 100
Overview 100
Diabetes Products 101
BRISTOL-MYERS SQUIBB 101
Overview 101
Problems with Generics 101
Diabetes Products 101
Pipeline 102
ELI LILLY AND CO. 102
Overview 102
Diabetes Products 102
Pipeline 103
GLAXO SMITHKLINE 103
Overview 103
Diabetes Products 103
Pipeline 104
JOHNSON & JOHNSON 104
Overview 104
Diabetes Products 104
Pipeline 105
MEDTRONIC 105
Overview 105
Diabetes Products 106
Pipeline 106
MERCK & CO. LTD. 106
Diabetes 107
SmartCells 107
MERCK KGAA 108
Overview 108
Diabetes Products 108
NOVARTIS INTERNATIONAL AG 109
Overview 109
Diabetes Products 109
Research 109
NOVO NORDISK A/S 110
Overview 110
Diabetes Products 110
Pipeline 111
TABLE 39 NOVO NORDISK DIABETES PRODUCT PIPELINE 112
ROCHE 112
Overview 112
Diabetes Products 113
Blood Glucose Monitoring Systems 113
Diabetes Data Management 114
Insulin Pump Systems 114
Lancet Devices 114
Other 115
Pipeline 115
SANOFI 115
Overview 115
Diabetes Products 116
TAKEDA 116
Overview 116
Pipeline 117
TABLE 40 DIABETES PRODUCTS IN DEVELOPMENT BY TAKEDA 117
OTHER COMPANIES 118
77 ELEKTRONIKA CO., LTD. 118
AGAMATRIX, INC. 118
ANIMAS CORP. 119
BIO-IMPEDANCE GENERAL LTD. 119
DEBIOTECH S.A. 120
INLIGHT SOLUTIONS, INC. 120
LIFESCAN, INC. 121
MANNKIND CORP. 121
A. MENARINI DIAGNOSTICS S.R.L. 122
NIPRO CORP. 3-9-3, 122
OWEN MUMFORD LTD. 123
PALCO LABS, INC. 124
PRODIGY DIABETES CARE LLC 124
TERUMO CORP. 125
TRANSITION THERAPEUTICS INC. 125
CHAPTER 9 APPENDIX I: ABOUT DIABETES 127
BLOOD SUGAR REGULATION 127
INSULIN 127
TYPE 1 DIABETES 128
TYPE 2 DIABETES 128
GESTATIONAL DIABETES 129
OBESITY-RELATED TYPE 2 DIABETES IN CHILDREN 129
MATURE-ONSET DIABETES OF THE YOUNG (MODY) 130
OTHER DIABETIC STATES 130
LATENT AUTOIMMUNE DIABETES (LADA) 130
PREDIABETES 130
DIAGNOSIS 131
GLUCOSE TESTS 131
OFFICIAL CRITERIA 131
DIFFERENTIAL DIAGNOSIS 131
TYPE 1 DIABETES 131
TYPE 2 DIABETES 132
CURRENT TREATMENT 132
TYPE 1 DIABETES 132
TYPE 2 DIABETES 132
Sulfonylureas 133
Biguanides 133
Alpha-Glucosidase Inhibitors 133
Glitazones (Thiazolidinediones) 134
Prandial Glucose Regulators 134
Incretin Mimetics 134
Dipeptidyl Peptidase 4 (DPP-4) Inhibitors 134
DIET 134
MONITORING DIABETES 134
BLOOD SUGAR CONTROL 134
THE DIABETES CONTROL AND COMPLICATIONS TRIAL (DCTT) 135
GLYCATED HEMOGLOBIN (HBA1C) 136
FRUCTOSAMINE 137
PREVALENCE OF DIABETES 137
TYPE 1 138
TYPE 2 138
DIABETIC COMPLICATIONS 138
RETINOPATHY 139
NEUROPATHY 139
NEPHROPATHY 140
INCREASED MORTALITY RISK 140
METABOLIC SYNDROME 140
CHAPTER 10 APPENDIX 2: GLOSSARY 143
TABLE 41 GLOSSARY 143
LIST OF TABLESSUMMARY TABLE DIABETES MARKET BREAKDOWN BY REGIONS, THROUGH 2017 ($BILLIONS) 6TABLE 1 GLOBAL AND REGIONAL DIABETES PREVALENCE, 2011 AND 2017 (CASES INMILLIONS) 8TABLE 2 TOTAL DIABETES MARKET IN 2012 ($ BILLIONS) 11TABLE 3 ADULT DIABETES MARKET BY REGION (MILLIONS/%) 12TABLE 4 MAJOR BRANDS OF INSULIN 18TABLE 5 INSULIN PENS 21TABLE 6 INSULIN PUMPS 28TABLE 7 SULFONYLUREAS 29TABLE 8 ORAL HYPOGLYCEMICS 32TABLE 9 INTERNATIONAL SUPPLIERS OF BLOOD LANCETS 34TABLE 10 SELECTED COMPANIES DEVELOPING NONINVASIVE GLUCOSE MONITORING 55TABLE 11 GLOBAL DIABETES MARKET, 2011 ($ BILLIONS) 67TABLE 12 GLOBAL SALES OF LEADING INSULIN PRODUCTS, 2011 ($ MILLIONS) 69TABLE 13 SALES OF OTHER ANTIDIABETIC DRUGS, 2011 ($ MILLIONS) 70TABLE 14 DIABETES MARKET BREAKDOWN BY REGION, THROUGH 2017 ($ BILLIONS) 71TABLE 15 LEADING SUPPLIERS OF GLUCOSE MONITORING PRODUCTS, 2011 (MILLIONS/%) 71TABLE 16 RISING PREVALENCE OF DIABETES BY REGION, THROUGH 2017 (CASES INMILLIONS) 72TABLE 17 TOTAL DIABETES MARKET FOR CANADA AND THE U.S., THROUGH 2017 ($BILLIONS) 73TABLE 18 TOTAL DIABETES MARKET FOR MEXICO AND BRAZIL, THROUGH 2017 ($ BILLIONS) 74TABLE 19 MAJOR EUROPEAN ECONOMIES: TOTAL DIABETES MARKET, THROUGH 2017 ($BILLIONS) 75TABLE 20 MAJOR ASIAN COUNTRIES: TOTAL DIABETES MARKET, THROUGH 2017 ($BILLIONS) 75TABLE 21 PREVALENCE OF DIABETES IN FRANCE, THROUGH 2017 (CASES IN MILLIONS) 79TABLE 22 FRANCE: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 79TABLE 23 FRANCE: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 79TABLE 24 PREVALENCE OF DIABETES IN GERMANY, THROUGH 2017 (CASES IN MILLIONS) 82TABLE 25 GERMANY: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 82TABLE 26 GERMANY: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 82TABLE 27 PREVALENCE OF DIABETES IN ITALY, THROUGH 2017 (CASES IN MILLIONS) 86TABLE 28 ITALY: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 86TABLE 29 ITALY: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 86TABLE 30 PREVALENCE OF DIABETES IN RUSSIA, THROUGH 2017 (CASES IN MILLIONS) 89TABLE 31 RUSSIA: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 89TABLE 32 RUSSIA: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 89TABLE 33 PREVALENCE OF DIABETES IN SPAIN, THROUGH 2017 (CASES IN MILLIONS) 92TABLE 34 SPAIN: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 92TABLE 35 SPAIN: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 92TABLE 36 PREVALENCE OF DIABETES IN THE U.K., THROUGH 2017 (CASES IN MILLIONS) 95TABLE 37 U.K.: DIABETES MEDICATIONS MARKET, THROUGH 2017 ($ BILLIONS) 96TABLE 38 U.K.: DIABETES DEVICES MARKET, THROUGH 2017 ($ BILLIONS) 96TABLE 39 NOVO NORDISK DIABETES PRODUCT PIPELINE 112TABLE 40 DIABETES PRODUCTS IN DEVELOPMENT BY TAKEDA 117TABLE 41 GLOSSARY 143
LIST OF FIGURES
SUMMARY FIGURE DIABETES MARKET EVOLUTION BY REGION, 2011-2017 ($ BILLIONS) 6
To order this report:Pathology Industry: Global Markets for Diabetes Therapeutics and Diagnostics -- Focus on EuropeContact
Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
Source: http://news.yahoo.com/global-markets-diabetes-therapeutics-diagnostics-140900590.html
super bowl halftime show 2012 ahmad bradshaw halftime super bowl 2012 super bowl score madonna super bowl performance superbowl commercials best superbowl commercials
Armored backpacks and a rush on guns after Conn.
Rick Brand, Chief Operating Officer of Amendment II, holds a children's backpack, left, and anti-ballistic insert at the company's manufacturing facility in Salt Lake City, Wednesday, Dec. 19, 2012. Anxious parents reeling in the wake the Connecticut school shooting are fueling sales of armored backpacks for children emblazoned with Disney and Avengers logos, as firearms enthusiasts stock up on assault rifles nationwide amid fears of imminent gun control measures. At Amendment II, sales of children?s backpacks and armored inserts are up 300 percent. (AP Photo/Rick Bowmer)
Rick Brand, Chief Operating Officer of Amendment II, holds a children's backpack, left, and anti-ballistic insert at the company's manufacturing facility in Salt Lake City, Wednesday, Dec. 19, 2012. Anxious parents reeling in the wake the Connecticut school shooting are fueling sales of armored backpacks for children emblazoned with Disney and Avengers logos, as firearms enthusiasts stock up on assault rifles nationwide amid fears of imminent gun control measures. At Amendment II, sales of children?s backpacks and armored inserts are up 300 percent. (AP Photo/Rick Bowmer)
This Wednesday, Dec. 19, 2012 photo shows an anti- ballistic insert for a children's backpack pierced by .40 cal., left, and .357 mag. rounds at the Amendment ll manufacturing facility in Salt Lake City. Anxious parents reeling in the wake the Connecticut school shooting are fueling sales of armored backpacks for children emblazoned with Disney and Avengers logos, as firearms enthusiasts stock up on assault rifles nationwide amid fears of imminent gun control measures. At Amendment II, sales of children?s backpacks and armored inserts are up 300 percent. (AP Photo/Rick Bowmer)
Rick Brand, Chief Operating Officer of Amendment II, holds a children's backpack with anti-ballistic insert during at the company's manufacturing facility in Salt Lake City, Wednesday, Dec. 19, 2012. Anxious parents reeling in the wake the Connecticut school shooting are fueling sales of armored backpacks for children emblazoned with Disney and Avengers logos, as firearms enthusiasts stock up on assault rifles nationwide amid fears of imminent gun control measures. At Amendment II, sales of children?s backpacks and armored inserts are up 300 percent. (AP Photo/Rick Bowmer)
SALT LAKE CITY (AP) ? The reaction to the Connecticut school shooting can be seen in gun stores and self-defense retailers across the nation: Anxious parents are fueling sales of armored backpacks for children while firearms enthusiasts are stocking up on assault rifles in anticipation of tighter gun control measures.
A spike in gun sales is common after a mass shooting, but the Connecticut tragedy has generated record sales in many states. Colorado set a single-day record for gun background check requests the day after the Connecticut mass shootings, and some online retailers are removing assault rifles from websites in part because of diminishing supplies.
Nevada saw more requests for background checks in the days after the shooting than any other weekend this year. Some gun shop owners are even holding back on sales, anticipating only more interest and value after President Barack Obama on Wednesday tasked his administration with creating concrete proposals to reduce gun violence.
Robert Akers, a Rapid City, S.D., gun seller specializing in assault-style rifles, said he has about 50 of the weapons in stock but he's not actively trying to sell them and has even turned off his phone.
"It's a madhouse," said Akers, owner of Rapid Fire Firearms. "Any time they have one of these shootings or an election, it gets that way. I don't even want to sell them right now because I won't be able to replace them for probably six months. ... The price is only going to go up higher."
At least three companies that make armored backpacks designed to shield children caught in a shootings also are reporting a large spike in sales and interest.
The body armor inserts fit into the back panel of a child's backpack, and they sell for about $150 to $300, depending on the company.
The armor is designed to stop bullets from handguns, not assault rifles like the one used by the Connecticut shooter. The manufacturers and some parents say that while they don't guarantee children won't be killed, they could still be used as shields.
"Just like a seatbelt increases your odds of surviving in a car crash, these increase your odds of surviving being shot," said Kerry Clark, president of Texas-based Backpackshield.com.
Ken Larson, 41, of Denver, Colo., already had an armored backpack for himself and convinced his wife to buy one for their 1-year-old after the Connecticut shooting on Friday, when a gunman stormed Sandy Hook Elementary in Newtown and massacred 20 first-graders and six adults.
"It's a no brainer. My son's life is invaluable," Larson said. "If I can get him a backpack for $200 that makes him safer, I don't even have to think about that. Where is my credit card?"
Though Larson knows the backpack won't guarantee his son's safety when he starts school, he says it's a worthy precaution.
"Kids already carry backpacks. When there is a shooting, you run for your life," he said. "Having it right there and on when he runs for his life gives him more safety."
Elmar Uy, vice president of operations at Bullet Blocker, a Massachusetts-based company that has sold the backpack armor since 2007, says the company's sales have tripled since last week.
At Amendment II in Salt Lake City, sales of children's backpacks and armored inserts are up 300 percent.
"The incident last week highlights the need to protect our children," said co-owner Derek Williams. "We didn't get in this business to do this. But the fact that is that our armor can help children just as it can help soldiers."
Amendment II was founded about two years ago using a new lightweight nanotechnology to make body armor products for soldiers and law enforcement less cumbersome. They began making the backpack inserts about six months ago, and also sell child-sized bulletproof vests. While the backpack sales still represent a minor part of the business, they now sell two varieties online ? one featuring Disney princesses and the other a scene from the movie Avengers.
Clark, president of Backpackshield.com, began making youth backpacks after the mass shooting at Virginia Tech in 2007.
"I don't do it for the money, but to save the lives of kids," Clark said. "We've got to do something more than just hide in the corner of the classroom."
___
Contributing to this report were Associated Press writers Allen G. Breed and Mitch Weiss in North Carolina; Scott Sonner in Nevada; Steven K. Paulson in Colorado; Dirk Lammers in South Dakota; Dylan T. Lovan in Kentucky; Brock Vergakis in Virginia; and Matt Gouras in Montana.
Associated Pressaaron carter black history month did groundhog see his shadow soul train don cornelius rod parsley barry sanders jr nick carter sister
20 000 ???? ?? iPhone 5 ?? ???? ????????? ? ????? ???? ?????? ??????
19 ???????? 2012 11:00,
????????? 403 ????
0
Source: http://www.nbcnews.com/technology/futureoftech/ibm-cognitive-computers-use-all-5-senses-1C7648130
radar weather morosini death jacoby ellsbury jacoby ellsbury lionel richie kenny rogers avatar the last airbender
Subscribe to:
Posts (Atom)